Journal
NATURE IMMUNOLOGY
Volume 22, Issue 2, Pages 106-108Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41590-020-00842-9
Keywords
-
Categories
Funding
- National Institute of Arthritis Musculoskeletal and Skin Disease grant [R01 AR073311]
- National Institutes of Health
Ask authors/readers for more resources
The study demonstrates successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.
A new study shows successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
